These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8459261)

  • 21. Teicoplanin biosynthesis genes in Actinoplanes teichomyceticus.
    Sosio M; Bianchi A; Bossi E; Donadio S
    Antonie Van Leeuwenhoek; 2000 Dec; 78(3-4):379-84. PubMed ID: 11386360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiological properties of teicoplanin.
    Greenwood D
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of teicoplanin biosynthesis: refining the roles of tei cluster-situated regulatory genes.
    Yushchuk O; Horbal L; Ostash B; Marinelli F; Wohlleben W; Stegmann E; Fedorenko V
    Appl Microbiol Biotechnol; 2019 May; 103(10):4089-4102. PubMed ID: 30937499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypoglycemic activity and tolerance of glibenclamide-phenformin association].
    Fanelli O; Bianchi G; Fascetti P; Trallori L
    Boll Chim Farm; 1971 Aug; 110(8):470-8. PubMed ID: 5002955
    [No Abstract]   [Full Text] [Related]  

  • 25. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
    Felmingham D; Brown DF; Soussy CJ
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-gram-positive agents. What we have and what we would like.
    Grüneberg RN
    Drugs; 1997; 54 Suppl 6():29-38. PubMed ID: 9474479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
    Brogden RN; Peters DH
    Drugs; 1994 May; 47(5):823-54. PubMed ID: 7520860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
    Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teicoplanin: an investigational glycopeptide antibiotic.
    Pryka RD; Rodvold KA; Rotschafer JC
    Clin Pharm; 1988 Sep; 7(9):647-58. PubMed ID: 2977108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Exogenous and endogenous insulin inhibit hyperlactacidemia induced in dogs by administration of phenformin].
    Loubatières A; Ribes G; Blayac JP
    C R Acad Hebd Seances Acad Sci D; 1973 Jan; 676(5):847-51. PubMed ID: 4196521
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of 18alpha-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats.
    Ao Y; Chen J; Yue J; Peng RX
    Eur J Pharmacol; 2008 Jun; 587(1-3):330-5. PubMed ID: 18462715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manipulating the regulatory genes for teicoplanin production in Actinoplanes teichomyceticus.
    Horbal L; Zaburannyy N; Ostash B; Shulga S; Fedorenko V
    World J Microbiol Biotechnol; 2012 May; 28(5):2095-100. PubMed ID: 22806031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of diphenylhydantoin and some oral hypoglycemic drugs related to carbohydrate metabolism in rats.
    Shehata MM
    Pol J Pharmacol Pharm; 1980; 32(1):11-4. PubMed ID: 7454606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VII. Preparation and NMR characteristics of the aglycone of teicoplanin.
    Malabarba A; Ferrari P; Gallo GG; Kettenring J; Cavalleri B
    J Antibiot (Tokyo); 1986 Oct; 39(10):1430-42. PubMed ID: 2946651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of glycopeptide antibiotics.
    Finch RG; Eliopoulos GM
    J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii5-13. PubMed ID: 15750036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetic characteristics and antimicrobial spectrum of teicoplanin].
    Paganini H; Marin M
    Medicina (B Aires); 2002; 62 Suppl 2():52-5. PubMed ID: 12481490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.